{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:08:07Z","timestamp":1789175287855,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["13697"],"award-info":[{"award-number":["13697"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003341","name":"Sarcoma Foundation of America","doi-asserted-by":"publisher","award":["1285412"],"award-info":[{"award-number":["1285412"]}],"id":[{"id":"10.13039\/100003341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.radonc.2025.111034","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T12:53:32Z","timestamp":1751633612000},"page":"111034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Balancing the dose: A meta-analysis of preoperative radiotherapy strategies for soft tissue sarcomas"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5445-4120","authenticated-orcid":false,"given":"G.F.","family":"Foppele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.H.G.","family":"van Riet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-4331","authenticated-orcid":false,"given":"R.L.M.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-4241","authenticated-orcid":false,"given":"L.M.","family":"Wiltink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111034_b0005","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial","volume":"359","author":"O'Sullivan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111034_b0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1096-9098(200004)73:4<206::AID-JSO4>3.0.CO;2-5","article-title":"Predictors of functional outcomes following limb salvage surgery for lower-extremity soft tissue sarcoma","volume":"73","author":"Davis","year":"2000","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0015","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.22298","article-title":"Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas","volume":"107","author":"Cannon","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111034_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2015.12.002","article-title":"Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies","volume":"119","author":"Haas","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.prro.2021.04.005","article-title":"Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline","volume":"11","author":"Salerno","year":"2021","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0030","unstructured":"Oncology NCPGi: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Soft Tissue Sarcoma Version 1.2024, 2024."},{"key":"10.1016\/j.radonc.2025.111034_b0035","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijrobp.2012.01.062","article-title":"Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?","volume":"84","author":"Haas","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111034_b0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111034_b0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13014-020-01695-0","article-title":"Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review","volume":"15","author":"Roeder","year":"2020","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0055","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111034_b0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1667\/RADE-20-00226.1","article-title":"Cellular Radiosensitivity of Soft Tissue Sarcoma","volume":"196","author":"Haas","year":"2021","journal-title":"Radiat. Res."},{"key":"10.1016\/j.radonc.2025.111034_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35542","article-title":"Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes","volume":"131","author":"Bishop","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111034_b0070","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S1470-2045(22)00638-6","article-title":"Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial","volume":"23","author":"Guadagnolo","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0075","doi-asserted-by":"crossref","unstructured":"Page MA-O, McKenzie JE, Bossuyt PM, et al: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","DOI":"10.31222\/osf.io\/v7gm2_v1"},{"key":"10.1016\/j.radonc.2025.111034_b0080","unstructured":"Sterne JAC HJ: The Risk Of Bias In Non-randomized Studies \u2013 of Interventions, Version 2 (ROBINS-I V2) assessment tool."},{"key":"10.1016\/j.radonc.2025.111034_b0085","unstructured":"Sterne JAC SJ, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al.: RoB 2: a revised tool for assessing risk of bias in randomised trials."},{"key":"10.1016\/j.radonc.2025.111034_b0090","unstructured":"Terminology Criteria for Adverse Events (CTCAE) Version 5.0, 2017."},{"key":"10.1016\/j.radonc.2025.111034_b0095","series-title":"Basic Clinical Radiobiology","year":"2025"},{"key":"10.1016\/j.radonc.2025.111034_b0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.radonc.2025.111034_b0105","unstructured":"R Core Team (2023). R: A Language and Environment for Statistical. Computing_. R Foundation for Statistical mputing V, Austria., https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.radonc.2025.111034_b0110","unstructured":"Safia K. Ahmed M: Hypofractionated Preoperative Radiation Therapy for Extremity and Superficial Trunk Soft Tissue Sarcomas: Results of a Prospective, Phase II Trial. Presented at the CTOS Annual Meeting 2024; San Diego. Session 7, paper 49."},{"key":"10.1016\/j.radonc.2025.111034_b0115","first-page":"3911","article-title":"Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma","volume":"32","author":"Shah","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.radonc.2025.111034_b0120","doi-asserted-by":"crossref","unstructured":"Gabriela Studer M, HoDab, Christoph Glanzmann, MDab, Franziska Maduz, BScNc, Beata Bode, MDd and Bruno Fuchs, MDbc: Preoperative IMRT for soft-tissue sarcoma of the extremities and trunk: low rate of wound complications. Current Orthopaedic Practice, 2018.","DOI":"10.1097\/BCO.0000000000000665"},{"key":"10.1016\/j.radonc.2025.111034_b0125","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1245\/s10434-010-1156-3","article-title":"Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma","volume":"17","author":"Canter","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jor.2024.02.042","article-title":"Assessment of local complications with preoperative versus postoperative radiotherapy in patients with soft tissue sarcoma in extremities: a randomized comparative clinical trial","volume":"53","author":"Abdallah","year":"2024","journal-title":"J. Orthop."},{"key":"10.1016\/j.radonc.2025.111034_b0135","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2022.07.001","article-title":"Final Safety and Health-Related Quality of LIfe Results of the Phase 2\/3 Act.In.Sarc Study with Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in locally Advanced Soft-Tissue Sarcoma","volume":"114","author":"Bonvalot","year":"2022","journal-title":"Int. J. radiation oncology, biology Phys."},{"key":"10.1016\/j.radonc.2025.111034_b0140","doi-asserted-by":"crossref","first-page":"804","DOI":"10.5603\/RPOR.a2021.0092","article-title":"Outcomes and computed tomography radiomic features extraction in soft tissue sarcomas treated with neoadjuvant radiation therapy","volume":"26","author":"Gonz\u00e1lez-Viguera","year":"2021","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.radonc.2025.111034_b0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12957-015-0515-8","article-title":"The treatment of periarticular soft tissue sarcoma following neo-adjuvant radiotherapy: a cohort study","volume":"13","author":"Green","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0150","doi-asserted-by":"crossref","unstructured":"Huang Z, Li N, Tang Y, et al: Neoadjuvant radiotherapy for soft tissue sarcoma in China: a preliminary result. ANNALS OF TRANSLATIONAL MEDICINE 10, 2022.","DOI":"10.21037\/atm-22-98"},{"key":"10.1016\/j.radonc.2025.111034_b0155","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ejso.2006.04.003","article-title":"Preoperative radiotherapy for soft tissue sarcoma: the Peter MacCallum Cancer Centre experience","volume":"32","author":"Hui","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0160","first-page":"978","article-title":"The IMRiS Trial: a phase 2 Study of Intensity Modulated Radiation Therapy in Extremity Soft Tissue Sarcoma","volume":"120","author":"Seddon","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111034_b0165","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/jso.25905","article-title":"Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival","volume":"121","author":"Shelby","year":"2020","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0170","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jamaoncol.2023.0042","article-title":"Pathologic complete Response and Clinical Outcomes in Patients with Localized Soft Tissue Sarcoma Treated with Neoadjuvant Chemoradiotherapy or Radiotherapy: the NRG\/RTOG 9514 and 0630 Nonrandomized Clinical Trials","volume":"9","author":"Wang","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115234","article-title":"Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas","volume":"217","author":"Foppele","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.radonc.2025.111034_b0180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12094-023-03237-y","article-title":"Moderate hypofractionated radiation therapy and pathologic response for soft tissue sarcomas (STS) of limbs and trunk: experience from a tertiary cancer center","volume":"26","author":"Montero","year":"2024","journal-title":"Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"},{"key":"10.1016\/j.radonc.2025.111034_b0185","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ejso.2014.05.016","article-title":"Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas","volume":"40","author":"Kosela-Paterczyk","year":"2014","journal-title":"European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"10.1016\/j.radonc.2025.111034_b0190","doi-asserted-by":"crossref","unstructured":"Kose\u0142a-Paterczyk H, Teterycz P, Spa\u0142ek MJ, et al: Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall. Cancers (Basel) 13, 2021.","DOI":"10.3390\/cancers13122981"},{"key":"10.1016\/j.radonc.2025.111034_b0195","doi-asserted-by":"crossref","unstructured":"Heesen P, Di Lonardo M, Ciobanu-Caraus O, et al: Ultrahypofractionated Versus Normofractionated Preoperative Radiotherapy for Soft Tissue Sarcoma: A Multicenter, Prospective Real-World-Time Phase 2 Clinical Trial. Cancers (Basel) 16, 2024.","DOI":"10.2139\/ssrn.4938057"},{"key":"10.1016\/j.radonc.2025.111034_b0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2478\/raon-2021-0038","article-title":"Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population","volume":"55","author":"Potkrajcic","year":"2021","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0205","first-page":"60","article-title":"Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience","volume":"21","author":"Kilic","year":"2017","journal-title":"Contemporary oncology (Poznan, Poland)"},{"key":"10.1016\/j.radonc.2025.111034_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.109439","article-title":"Early outcomes of ultra-hypofractionated preoperative radiation therapy for soft tissue sarcoma followed by immediate surgical resection","volume":"180","author":"Mayo","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0215","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.adro.2020.06.024","article-title":"Early Outcomes of Preoperative 5-Fraction Radiation Therapy for Soft Tissue Sarcoma Followed by Immediate Surgical Resection","volume":"5","author":"Parsai","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0220","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1078-0432.CCR-19-3524","article-title":"A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma","volume":"26","author":"Kalbasi","year":"2020","journal-title":"Clin. Cancer Res. official J. Am. Association Cancer Res."},{"key":"10.1016\/j.radonc.2025.111034_b0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2021.05.025","article-title":"Preoperative stereotactic ablative body radiotherapy with postoperative conventional irradiation of soft tissue sarcomas: Protocol overview with a preliminary safety report","volume":"161","author":"Novikov","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0230","doi-asserted-by":"crossref","unstructured":"Kubicek GJ, Kim TW, Gutowski CJ, et al: Preoperative Stereotactic Body Radiation Therapy for Soft-Tissue Sarcoma: Results of Phase 2 Study. ADVANCES IN RADIATION ONCOLOGY 7, 2022.","DOI":"10.1016\/j.adro.2021.100855"},{"key":"10.1016\/j.radonc.2025.111034_b0235","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/COC.0000000000000236","article-title":"Preoperative Radiosurgery for Soft Tissue Sarcoma","volume":"41","author":"Kubicek","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.radonc.2021.06.027","article-title":"Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities","volume":"161","author":"Leite","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0245","article-title":"Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma","volume":"7","author":"Bedi","year":"2022","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111034_b0255","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1302\/2046-3758.110.2000104","article-title":"Revision surgery is overestimated in hip replacement","volume":"1","author":"Keurentjes","year":"2012","journal-title":"Bone Joint Res"},{"key":"10.1016\/j.radonc.2025.111034_b0260","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1200\/JCO.24.00238","article-title":"Hypofractionated Preoperative Radiation Should not yet Be used as Standard of Care for Extremity and Truncal Soft Tissue Sarcoma","volume":"42","author":"Baldini","year":"2024","journal-title":"J. Clin. Oncol."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025045384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025045384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:28:09Z","timestamp":1789172889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025045384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":51,"alternative-id":["S0167814025045384"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111034","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Balancing the dose: A meta-analysis of preoperative radiotherapy strategies for soft tissue sarcomas","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111034"}}